SPYBIOTECH
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centers with a new and modified technology to develop vaccines which give better results in lesser time.
SPYBIOTECH
Industry:
Biotechnology Life Science Medical
Founded:
2017-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.spybiotech.com
Total Employee:
11+
Status:
Active
Contact:
+4401865582088
Email Addresses:
[email protected]
Total Funding:
41.59 M USD
Technology used in webpage:
Google Maps GoDaddy
Similar Organizations
Refeyn
Refeyn is specialising in label-free single molecule imaging and mass measurement.
AxoSim
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.
Baseimmune
Baseimmune is a biotech startup founded to create the next generation of vaccines.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Lava Therapeutics
Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.
Alpenglow Biosciences
Alpenglow Biosciences is an end-to-end 3D pathology platform that aims to accelerate drug development and improve clinical diagnostics.
Nature Metrics
Nature Metrics is an award-winning technology start-up using cutting-edge genetic techniques to monitor biodiversity.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
ONI
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
Oxitec
Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - SpyBiotech
The Future Fund
The Future Fund investment in Series A - SpyBiotech
Google Ventures
Google Ventures investment in Series A - SpyBiotech
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - SpyBiotech
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP investment in Series A - SpyBiotech
Braavos Investment Advisers
Braavos Investment Advisers investment in Series A - SpyBiotech
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - SpyBiotech
Google Ventures
Google Ventures investment in Seed Round - SpyBiotech
Key Employee Changes
| Date | New article |
|---|---|
| 2024-06-18 | SpyBiotech Appoints Keith Dewedoff as new Chief Financial Officer |
| 2022-07-12 | SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer |
Official Site Inspections
http://www.spybiotech.com
- Host name: 107.223.169.192.host.secureserver.net
- IP address: 192.169.223.107
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "SpyBiotech"
Homepage - SpyBiotech
Jun 18, 2024 SpyBiotech is a clinical stage company utilizing its unique protein superglue technology to develop vaccines against infectious disease and cancer. Preventing disease by triggering the body’s own immune system is one of …See details»
SpyBiotech - Crunchbase Company Profile & Funding
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used …See details»
Our Story - SpyBiotech
SpyBiotech plans to begin a Phase I clinical study of its internal lead candidate, targeting cytomegalovirus (CMV), in 2023. We also welcomed Simon Jones as VP of Finance and Operations. We raised £10m in convertible debt funding …See details»
SpyBiotech - LinkedIn
SpyBiotech | 2,143 followers on LinkedIn. Utilizing unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide | SpyBiotech is a UK-based …See details»
SpyBiotech Company Profile 2025: Valuation, Funding & Investors
SpyBiotech was founded in 2017. Where is SpyBiotech headquartered? SpyBiotech is headquartered in Oxford, United Kingdom. What is the size of SpyBiotech? SpyBiotech has 23 …See details»
SpyBiotech Company Profile - Office Locations, Competitors
SpyBiotech $37.49 m in total funding, and £41.95 k in annual revenue in FY 2019. See insights on SpyBiotech including office locations, competitors, revenue, financials, executives, …See details»
Our Team - SpyBiotech
Our Team We’re a dynamic team, dedicated to developing new vaccinesWe combine outstanding scientific talent with proven commercial and operational expertise. MarkLeuchtenbergerChief Executive Officer SumiBiswasPresident, …See details»
About SpyBiotech - pharmiweb.jobs
Dec 7, 2023 SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and chronic diseases.The company was spun out of the University of Oxford in 2017 by …See details»
SPYBIOTECH LIMITED Company Profile - Dun & Bradstreet
Spybiotech limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / oxford / …See details»
SpyBiotech - Company Profile - Tracxn
SpyBiotech - Developer of vaccines for bacterial infections and cancer by using proprietary protein superglue technology. Raised a total funding of $39M over 3 rounds from 7 investors. Valued …See details»
SpyBiotech - Products, Competitors, Financials, Employees, …
SpyBiotech's primary market includes the healthcare sector, particularly in vaccine development for diseases lacking effective treatment or prevention. It was founded in 2017 and is based in …See details»
SpyBiotech - VentureRadar
SpyBiotech have developed unique technology to transform how vaccines are created. Features: Unique access to protein superglue for vaccines: SpyTag/SpyCatcher; Rapid and irreversible …See details»
Spybiotech Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Spybiotech Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 14 news, and 4 literature, Disease Domain:Infectious Diseases, Technology …See details»
Meet the Founder: Sumi Biswas, CEO of SpyBiotech
Dec 16, 2020 What is SpyBiotech’s ‘protein superglue’ technology? Our proprietary ‘protein superglue’ is a technology which allows researchers to quickly and efficiently generate new …See details»
SpyBiotech - Oxford Science Enterprises
Latest News All Company News 13•08•24 Portfolio News SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer 23•07•24 Portfolio News SpyBiotech Announces the …See details»
SpyBiotech - Oxford Investment Consultants
SpyBiotech was spun out of the University of Oxford’s Jenner Institute and Department of Biochemistry in 2017 to develop an innovative ‘plug and display’ platform technology for the …See details»
Contact Us - SpyBiotech
We are seeking high quality and motivated individuals to join our team and make strides in developing therapies for hard-to-cure disease.See details»
SpyBiotech Reviews: What Is It Like to Work At SpyBiotech?
May 27, 2024 2 SpyBiotech reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»
Our Technology - SpyBiotech
SpyBiotech’s proprietary technology has an exceptionally broad range of applications in vaccine development. The simple, efficient and irreversible reaction between the peptide SpyTag and …See details»
News - SpyBiotech
Aug 12, 2024 SpyBiotech Receives Grant to Advance Novel SpyVector Platform That Improves Efficacy and Boosting Capability of Adenovirus-based Vaccines Against Current and Future …See details»